Skip to main navigation Skip to search Skip to main content

Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: Insights from the ABSORB trial

  • Salvatore Brugaletta
  • , Josep Gomez-Lara
  • , Nico Bruining
  • , Maria D. Radu
  • , Robert Jan Van Geuns
  • , Leif Thuesen
  • , Dougal McClean
  • , Jacques Koolen
  • , Stephan Windecker
  • , Robert Whitbourn
  • , James Oberhauser
  • , Richard Rapoza
  • , John A. Ormiston
  • , Hector M. Garcia-Garcia
  • , Patrick W. Serruys
  • Erasmus MC
  • Hospital Clínic
  • Aarhus University Hospital
  • Christchurch Hospital New Zealand
  • Catharina Hospital
  • University Hospital of Psychiatry
  • St Vincent's Hospital
  • Abbott Vascular
  • Auckland City Hospital
  • Cardialysis BV

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

5 Citations (Scopus)

Abstract

Aims: To analyse and to compare the changes in the various optical coherence tomography (OCT), echogenicity and intravascular ultrasound virtual histology (VH) of the everolimus-eluting bioresorbable scaffold (ABSORB) degradation parameters during the first 12 months after ABSORB implantation. In the ABSORB study, changes in the appearance of the ABSORB scaffold were monitored over time using various intracoronary imaging modalities. The scaffold struts exhibited a progressive change in their black core area by OCT, in their ultrasound derived grey level intensity quantified by echogenicity, and in their backscattering ultrasound signal, identified as "pseudo dense-calcium" (DC) by VH. Methods and results: From the ABSORB Cohort B trial 35 patients had paired OCT, echogenicity and VH assessment at baseline and at six- (n=18) or 12-months follow-up (n=17). Changes in OCT strut core area, hyperechogenicity and VH-derived DC were analysed and compared at the various time points. At six months, the change (median[IQR]) in OCT strut core area was -7.2% (-14.0-+0.9) (p=0.053), in hyperechogenicity -12.7% (-33.7-+1.4) (p=0.048) and VH-DC 22.1% (-10.8-+48.8) (p=0.102). At 12 months, all the imaging modalities showed a decrease in the various parameters considered (OCT: -12.2% [-17.5- -1.9], p=0.093; hyperechogenicity -24.64% [-36.6- -16.5], p=0.001; VH-DC: -24.66% [-32.0- -7.0], p=0.071). However, the correlation between the relative changes in these parameters was statistically poor (Spearman's rho <0.4). Conclusions: OCT, echogenicity and VH were able to detect changes in the ABSORB scaffold struts, although the correlation between those changes was poor. This is likely due to the fact that each imaging modality interrogates different material properties on different length scales. Further studies are needed to explore these hypotheses.

Original languageEnglish
Pages (from-to)352-358
Number of pages7
JournalEuroIntervention
Volume8
Issue number3
DOIs
Publication statusPublished - Jul 2012
Externally publishedYes

Keywords

  • Imaging
  • OCT
  • Virtual histology

Fingerprint

Dive into the research topics of 'Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: Insights from the ABSORB trial'. Together they form a unique fingerprint.

Cite this